330 related articles for article (PubMed ID: 25453487)
1. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
[TBL] [Abstract][Full Text] [Related]
3. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2014; 41(4):1223-8. PubMed ID: 24787914
[TBL] [Abstract][Full Text] [Related]
5. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
6. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2015 Jul; 30(4):202-8. PubMed ID: 26011780
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.
Moga DC; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Wu Q; Jicha GA; Gnjidic D
Drugs Aging; 2017 Jan; 34(1):55-65. PubMed ID: 27896799
[TBL] [Abstract][Full Text] [Related]
9. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
[TBL] [Abstract][Full Text] [Related]
10. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.
Tolppanen AM; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
BMJ Open; 2016 Jul; 6(7):e012100. PubMed ID: 27412109
[TBL] [Abstract][Full Text] [Related]
11. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study.
Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S
Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.
Sarycheva T; Taipale H; Lavikainen P; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
J Alzheimers Dis; 2018; 66(1):387-395. PubMed ID: 30282366
[TBL] [Abstract][Full Text] [Related]
13. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
[TBL] [Abstract][Full Text] [Related]
14. Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.
Tolppanen AM; Voutilainen A; Taipale H; Tanskanen A; Lavikainen P; Koponen M; Tiihonen J; Hartikainen S
PLoS One; 2017; 12(3):e0173450. PubMed ID: 28278245
[TBL] [Abstract][Full Text] [Related]
15. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort.
Taipale H; Purhonen M; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S
Scand J Public Health; 2016 Mar; 44(2):150-8. PubMed ID: 26553247
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study.
Koponen M; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Ahonen R; Hartikainen S
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1706-13. PubMed ID: 26233607
[TBL] [Abstract][Full Text] [Related]
17. Incident ischaemic heart disease in persons with Alzheimer's disease in a Finnish nationwide exposure-matched cohort.
Tolppanen AM; Kettunen R; Ahonen R; Soininen H; Hartikainen S
Int J Cardiol; 2013 Dec; 170(2):195-201. PubMed ID: 24200309
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Clin Psychopharmacol; 2014 Aug; 34(4):435-40. PubMed ID: 24875073
[TBL] [Abstract][Full Text] [Related]
19. Use of antiepileptic drugs among community-dwelling persons with Alzheimer's disease in Finland.
Bell JS; Lönnroos E; Koivisto AM; Lavikainen P; Laitinen ML; Soininen H; Hartikainen S
J Alzheimers Dis; 2011; 26(2):231-7. PubMed ID: 21593561
[TBL] [Abstract][Full Text] [Related]
20. Incident hip fractures among community dwelling persons with Alzheimer's disease in a Finnish nationwide register-based cohort.
Tolppanen AM; Lavikainen P; Soininen H; Hartikainen S
PLoS One; 2013; 8(3):e59124. PubMed ID: 23527106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
